Protagonist Therapeutics Inc

NASDAQ:PTGX   12:48:10 PM EDT
42.97
-0.47 (-1.08%)
Products

Protagonist Therapeutics Receives FDA Breakthrough Therapy Designation For Rusfertide In Polycythemia Vera

Published: 06/03/2021 12:04 GMT
Protagonist Therapeutics Inc (PTGX) - Protagonist Therapeutics Receives FDA Breakthrough Therapy Designation for Rusfertide in Polycythemia Vera.